CONNECT WITH US
Gaming

Gaming

If New Blood had made Dusk 2, there'd be no Iron Lung, 'and now David Szymanski has got a movie that made $50 million'—so maybe there's wisdom in not churning out sequels

PC Gamer logo

Published on

Add as a preferred source on Google
If New Blood had made Dusk 2, there'd be no Iron Lung, 'and now David Szymanski has got a movie that made $50 million'—so maybe there's wisdom in not churning out sequels

New Blood boss Dave Oshry isn't interested in running a massive studio that follows the blockbuster strategy of milking its successful games for all they're worth. The publisher-developer combo has enjoyed a string of big wins with its boomer shooters, but Oshry's plan for building on success is to invest that money into new projects.

"I think a lot of studios would have a big hit like Ultrakill," Oshry tells us, "and then they would maybe open a big office, or just milk the shit out of Ultrakill and do Ultrakill spinoffs, or use that money to make sequels. And I've decided to put that money into projects like Gloomwood and Fallen Aces, artsy projects like Tenebris Somnia. That’s what I've decided to do with our success because I can, because we're independent."

The goal, says Oshry, has never been to create "a big studio with an office and hundreds of employees … I don't know why anyone would want that". And thankfully he doesn't have to deal with shareholders and investors telling him to just keep milking and keep growing.

"The fact that we're one studio and that I control everything means that I can make those kinds of decisions," he says. ’ They would be like, ‘You need to be working on Ultrakill spinoff games. You need to be working on Dusk 2, Faith: Chapter Four. Why haven't you made a survival crafting game out of this yet? ’ And we're just like, ‘What cool thing do we want to do?


Source link

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.